José V Menani Selected Research

pyrrolidonyl-beta-naphthylamide

1/2019	Central muscarinic and LPBN mechanisms on sodium intake.
10/2011	Changes in taste reactivity to intra-oral hypertonic NaCl after lateral parabrachial injections of an α2-adrenergic receptor agonist.
11/2007	Enhancement of meal-associated hypertonic NaCl intake by moxonidine into the lateral parabrachial nucleus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José V Menani Research Topics

Disease

8	Body Weight (Weight, Body) 11/2019 - 08/2007
8	Dehydration (Water Stress) 12/2016 - 08/2002
5	Hypotension (Low Blood Pressure) 10/2011 - 06/2004
5	Bradycardia 08/2009 - 06/2004
4	Hypercapnia 01/2020 - 02/2011
3	Hypertension (High Blood Pressure) 11/2019 - 11/2009
2	Hypoxia (Hypoxemia) 01/2013 - 12/2011
2	Hypovolemia 10/2011 - 07/2010
1	Obesity 11/2019
1	Renovascular Hypertension (Goldblatt Syndrome) 01/2018
1	Necrosis 02/2016
1	Pica (Geophagia) 10/2011
1	Hyperemia 10/2011
1	Infections 02/2011
1	Tachycardia (Tachyarrhythmias) 05/2006

Drug/Important Bio-Agent (IBA)

6	moxonidine (Moxon)IBA 01/2019 - 06/2004
6	SodiumIBA 12/2016 - 08/2002
4	MuscimolIBA 01/2013 - 08/2007
3	Pilocarpine (Ocusert)FDA LinkGeneric 01/2019 - 11/2009
3	pyrrolidonyl-beta-naphthylamideIBA 01/2019 - 11/2007
3	gamma-Aminobutyric Acid (GABA)IBA 01/2013 - 02/2011
3	Stainless Steel (Steel, Stainless)IBA 12/2011 - 04/2009
3	Urethane (Ethyl Carbamate)IBA 12/2011 - 08/2007
3	MineralsIBA 10/2011 - 06/2005
3	Furosemide (Lasix)FDA LinkGeneric 10/2011 - 06/2005
2	Cholinergic Agents (Cholinergics)IBA 01/2020 - 11/2009
2	Muscarinic AntagonistsIBA 01/2020 - 01/2019
2	ReninIBA 11/2019 - 07/2010
2	Glutamic Acid (Glutamate)FDA Link 08/2009 - 10/2004
2	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 05/2006 - 10/2004
2	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 05/2006 - 10/2004
2	Potassium CyanideIBA 05/2006 - 10/2004
1	MecamylamineIBA 01/2020
1	Atropine FDA LinkGeneric 01/2020
1	Cholinergic ReceptorsIBA 01/2020
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2020
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2020
1	AngiotensinsIBA 11/2019
1	Carbachol (Carbastat)FDA Link 11/2019
1	methoctramineIBA 01/2019
1	PirenzepineIBA 01/2019
1	SilverIBA 01/2018
1	Sucrose (Saccharose)IBA 12/2016
1	InterleukinsIBA 02/2016
1	Sodium Chloride FDA LinkGeneric 05/2013
1	Baclofen FDA LinkGeneric 05/2013
1	Irritants (Vesicants)IBA 10/2011
1	Imidazoline ReceptorsIBA 10/2011
1	Captopril (Capoten)FDA LinkGeneric 10/2011
1	SaltsIBA 10/2011
1	KaolinIBA 10/2011
1	Acetic Acid (Vinegar)FDA LinkGeneric 10/2011
1	DiureticsIBA 02/2011
1	EndotoxinsIBA 02/2011
1	Angiotensin IIIBA 07/2010
1	Muscarinic AgonistsIBA 11/2009
1	salicylhydroxamic acid (SHAM)IBA 10/2009
1	CatalaseIBA 08/2009
1	Kynurenic Acid (Kynurenate)IBA 08/2009
1	Amitrole (Aminotriazole)IBA 08/2009
1	GABA-A Receptor AgonistsIBA 08/2007
1	Yohimbine (Yocon)IBA 06/2007
1	PotassiumIBA 06/2005
1	IsomolarIBA 06/2005
1	SolutionsIBA 06/2005
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 06/2004
1	Saline SolutionIBA 08/2002

Therapy/Procedure

5	Injections 12/2011 - 08/2007
3	Cannula 12/2011 - 04/2009
2	Subcutaneous Injections 10/2011 - 06/2005
1	Surgical Instruments (Clip) 01/2018
1	Controlled Hypotension 06/2004